QCM-D studies of human norovirus VLPs binding to glycosphingolipids in supported lipid bilayers reveal strain-specific characteristics

Glycobiology

Volumn 19, Issue 11, 2009, Pages 1176-1184

  Rydell, Gustaf E ^a   Dahlin, Andreas B ^b   Höök, Fredrik ^b   Larson, Göran ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Glycosphingolipid; H type 1; Norovirus; QCM D; Supported lipid bilayer

Indexed keywords

GLYCOSPHINGOLIPID; GLYCOSPHINGOLIPID H TYPE 1; GLYCOSPHINGOLIPID LEWIS; GLYCOSYLCERAMIDASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING KINETICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; LIPID ANALYSIS; LIPID BILAYER; MEMBRANE BINDING; MEMBRANE FORMATION; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; QUARTZ CRYSTAL MICROBALANCE; STRAIN DIFFERENCE; THIN LAYER CHROMATOGRAPHY; VIRUS ATTACHMENT; VIRUS LIKE AGENT; VIRUS MORPHOLOGY; VIRUS STRAIN;

BINDING SITES; CRYSTALLIZATION; GLYCOSPHINGOLIPIDS; HUMANS; LIPID BILAYERS; NOROVIRUS; QUARTZ;

NOROVIRUS;

EID: 70349991887     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwp103     Document Type: Article

References (60)

1. Atmar RL, Estes MK. 2006. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am. 35:275-290, viii.
2. Bingen P, Wang G, Steinmetz NF, Rodahl M, Richter RP. 2008. Solvation effects in the quartz crystal microbalance with dissipation monitoring response to biomolecular adsorption. A phenomenological approach. Anal Chem. 80:8880-8890.
3. Bu W, Mamedova A, Tan M, Xia M, Jiang X, Hegde RS. 2008. Structural basis for the receptor binding specificity of Norwalk virus. J Virol 82:5340-5347.
4. Cao S, Lou Z, Tan M, Chen Y, Liu Y, Zhang Z, Zhang XC, Jiang X, Li X, Rao Z. 2007. Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol. 81:5949-5957.
5. Chan MC, Wong YP, Leung WK. 2007. Cell culture assay for human noroviruses. Emerg Infect Dis. 13:1117; author reply 1117-1118.
6. Chen R, Neill JD, Noel JS, Hutson AM, Glass RI, Estes MK, Prasad BV. 2004. Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol. 78:6469-6479.
7. Choi JM, Hutson AM, Estes MK, Prasad BV. 2008. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci USA. 105:9175-9180.
8. Cooling LL, Koerner TA, Naides SJ. 1995. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis. 172:1198-1205.
9. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK. 2004. Laboratory efforts to cultivate noroviruses. J Gen Virol. 85:79-87.
10. Evans SV, Roger MacKenzie C. 1999. Characterization of protein-glycolipid recognition at the membrane bilayer. J Mol Recognit. 12:155-168.
11. Green KY, Lew JF, Jiang X, Kapikian AZ, Estes MK. 1993. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol. 31:2185-2191.
12. Guix S, Asanaka M, Katayama K, Crawford SE, Neill FH, Atmar RL, Estes MK. 2007. Norwalk virus RNA is infectious in mammalian cells. J Virol 81:12238-12248.
13. Hansson GC, Karlsson KA, Larson G, Stromberg N, Thurin J, Orvell C, Norrby E. 1984. A novel approach to the study of glycolipid receptors for viruses. Binding of Sendai virus to thin-layer chromatograms. FEBS Lett. 170:15-18.
14. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. 2002. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol. 76:12335-12343.
15. Harrington PR, Vinje J, Moe CL, Baric RS. 2004. Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J Virol. 78:3035-3045.
16. Hibbert DB, Gooding JJ, Erokhin P. 2002. Kinetics of irreversible adsorption with diffusion: Application to biomolecule immobilization. Langmuir. 18:1770-1776.
17. Hook F, Rodahl M, Kasemo B, Brzezinski P. 1998. Structural changes in hemoglobin during adsorption to solid surfaces: Effects of pH, ionic strength, and ligand binding. Proc Natl Acad Sci USA. 95:12271-12276.
18. Huang P, Farkas T, Zhong W, Tan M, Thornton S, Morrow AL, Jiang X. 2005. Norovirus and histo-blood group antigens: Demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol. 79:6714-6722.
19. Hutson AM, Airaud F, LePendu J, Estes MK, Atmar RL. 2005. Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol. 77:116-120.
20. Hutson AM, Atmar RL, Marcus DM, Estes MK. 2003. Norwalk virus-like particle hemagglutination by binding to H histo-blood group antigens. J Virol. 77:405-415.
21. Jiang X, Wang M, Graham DY, Estes MK. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol. 66:6527-6532.
22. Johansson P, Nilsson J, Angstrom J, Miller-Podraza H. 2005. Interaction of Helicobacter pylori with sialylated carbohydrates: The dependence on different parts of the binding trisaccharide Neu5Ac{alpha}3Gal{beta}4GlcNAc. Glycobiology. 15:625-636.
23. Karlsson KA. 1987. Preparation of total nonacid glycolipids for overlay analysis of receptors for bacteria and viruses and for other studies. Methods Enzymol. 138:212-220.
24. Karlsson KA. 2001. Pathogen-host protein-carbohydrate interactions as the basis of important infections. Adv Exp Med Biol. 491:431-443.
25. Karlsson KA, Larson G. 1981. Molecular characterization of cell surface antigens of fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human O Le(a - b+) secretor. J Biol Chem. 256:3512-3524.
26. Karlsson KA, Stromberg N. 1987. Overlay and solid-phase analysis of glycolipid receptors for bacteria and viruses. Methods Enzymol. 138:220-232.
27. Kaufmann B, Baxa U, Chipman PR, Rossmann MG, Modrow S, Seckler R. 2005. Parvovirus B19 does not bind to membrane-associated globoside in vitro. Virology. 332:189-198.
28. Keller CA, Kasemo B. 1998. Surface specific kinetics of lipid vesicle adsorption measured with a quartz crystal microbalance. Biophys J. 75:1397-1402.
29. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. 1995. Sequence and expression of a candidate for the human secretor blood group alpha (1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem. 270:4640-4649.
30. Kindberg E, Akerlind B, Johnsen C, Knudsen JD, Heltberg O, Larson G, Bottiger B, Svensson L. 2007. Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J Clin Microbiol. 45:2720-2722.
31. Kroneman A, Verhoef L, Harris J, Vennema H, Duizer E, van Duynhoven Y, Gray J, Iturriza M, Bottiger B, Falkenhorst G, et al. 2008. Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the foodborne viruses in Europe network from 1-7-2001 to 30-6-2006. J Clin Microbiol. 46:2959-2965.
32. 2. Anal Chem. 75:5080-5087.
33. Larsson MM, Rydell GE, Grahn A, Rodriguez-Diaz J, Akerlind B, Hutson AM, Estes MK, Larson G, Svensson L. 2006. Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis. 194:1422-1427.
34. Le Pendu J, Ruvoen-Clouet N, Kindberg E, Svensson L. 2006. Mendelian resistance to human norovirus infections. Semin Immunol. 18:375-386.
35. Lindesmith L, Moe C, Lependu J, Frelinger JA, Treanor J, Baric RS. 2005. Cellular and humoral immunity following Snow Mountain virus challenge. J Virol. 79:2900-2909.
36. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat Med. 9:548-553.
37. Lingwood CA. 1996. Aglycone modulation of glycolipid receptor function. Glycoconj J. 13:495-503.
38. Low JA, Magnuson B, Tsai B, Imperiale MJ. 2006. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J Virol. 80:1361-1366.
39. Mammen M, Choi SK, Whitesides GM. 1998. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed. 37:2754-2794.
40. Marionneau S, Airaud F, Bovin NV, Le Pendu J, Ruvoen-Clouet N. 2005. Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J Infect Dis. 192:1071-1077.
41. Marionneau S, Ruvoen N, Le Moullac-Vaidye B, Clement M, Cailleau-Thomas A, Ruiz-Palacois G, Huang P, Jiang X, Le Pendu J. 2002. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology. 122:1967-1977.
42. Nicollier-Jamot B, Pico V, Pothier P, Kohli E. 2003. Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France. J Clin Microbiol. 41:3901-3904.
43. Nilsson J, Rydell GE, Le Pendu J, Larson G. 2009. Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids. Glycoconj J. April 23 (E-pub ahead of print), PMID 19387828.
44. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD. 2008. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis. 14:1224-1231.
45. Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, Estes MK. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science 286:287-290.
46. Rockx BH, Vennema H, Hoebe CJ, Duizer E, Koopmans MP. 2005. Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis. 191:749-754.
47. Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine G, Blanchard D, Le Pendu J. 2000. Binding of rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family. J Virol. 74:11950-11954.
48. Rydell GE, Nilsson J, Rodriguez-Diaz J, Ruvoen-Clouet N, Svensson L, Le Pendu J, Larson G. 2009. Human noroviruses recognize sialyl Lewis x neoglycoprotein. Glycobiology. 19:309-320.
49. Sackmann E. 1996. Supported membranes: Scientific and practical applications. Science. 271:43-48.
50. Shirato H, Ogawa S, Ito H, Sato T, Kameyama A, Narimatsu H, Xiaofan Z, Miyamura T, Wakita T, Ishii K, et al. 2008. Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol. 82:10756-10767.
51. Stahl E. 1967. Dünnschichtchromatographie. Berlin: Springer. p. 817.
52. Straub TM, Honer zu Bentrup K, Orosz-Coghlan P, Dohnalkova A, Mayer BK, Bartholomew RA, Valdez CO, Bruckner-Lea CJ, Gerba CP, Abbaszadegan M, et al. 2007. In vitro cell culture infectivity assay for human noroviruses. Emerg Infect Dis. 13:396-403.
53. Stromberg N, Nyholm PG, Pascher I, Normark S. 1991. Saccharide orientation at the cell surface affects glycolipid receptor function. Proc Natl Acad Sci USA. 88:9340-9344.
54. Tamura M, Natori K, Kobayashi M, Miyamura T, Takeda N. 2004. Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane. J Virol. 78:3817-3826.
55. Tan M, Jin M, Xie H, Duan Z, Jiang X, Fang Z. 2008. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol. 80:1296-1301.
56. Tan M, Xia M, Cao S, Huang P, Farkas T, Meller J, Hegde RS, Li X, Rao Z, Jiang X. 2008. Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology. 379:324-334.
57. Taube S, Perry JW, Yetming K, Patel SP, Auble H, Shu L, Nawar HF, Lee CH, Connell TD, Shayman JA, et al. 2009. Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses (MNV). J Virol. 83:4092-4101.
58. Thorven M, Grahn A, Hedlund KO, Johansson H, Wahlfrid C, Larson G, Svensson L. 2005. A homozygous nonsense mutation (428G→A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol. 79:15351-15355.
59. Tsai B, Gilbert JM, Stehle T, Lencer W, Benjamin TL, Rapoport TA. 2003. Gangliosides are receptors for murine polyoma virus and SV40. Embo J 22:4346-4355.
60. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. 2006. Norovirus classification and proposed strain nomenclature. Virology 346:312-323.